These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 9445605)
1. [Effect of transient cerebral ischemia on the synthesis of prostacyclin in dogs with arterial hypertension]. Aliev MA; Lemeshenko VA; Bekbolotova AK Biull Eksp Biol Med; 1997 Sep; 124(9):280-2. PubMed ID: 9445605 [No Abstract] [Full Text] [Related]
2. [Possible role of prostacyclin in the pathogenesis of cerebral circulatory disorders]. Akopov SE; Gabrielian ES; Tunian IuS Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(8):1146-50. PubMed ID: 3901630 [TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis of ischemic disorders of the cerebral circulation in arterial hypertension]. Vysotskaia VG; Lebedeva NV; Lobkova TN; Suslina Za; Khrapova EV Klin Med (Mosk); 1985 Apr; 63(4):36-41. PubMed ID: 4033001 [No Abstract] [Full Text] [Related]
4. [The antiaggregation activity of the normal cerebral vessels and in ischemia]. Petrishchev NN; Shestakova SA; Dorokhova LN; Mel'nikova EV Fiziol Zh SSSR Im I M Sechenova; 1989 Nov; 75(11):1515-20. PubMed ID: 2628008 [No Abstract] [Full Text] [Related]
5. [Clinical course and risk factors in transient cerebral ischemia]. Ott E Wien Med Wochenschr; 1975 May; 125(22-24):374-6. PubMed ID: 1146343 [No Abstract] [Full Text] [Related]
6. [Changes in blood platelet aggregation in patients with cerebral ischemia]. Modravý V; Effler J; Morán M; Goderová Z Cas Lek Cesk; 1988 Jan; 127(2):39-42. PubMed ID: 3356025 [No Abstract] [Full Text] [Related]
7. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension. Islim IF; Bareford D; Beevers DG Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379 [TBL] [Abstract][Full Text] [Related]
8. Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation. Patki KC; Joglekar SJ; Kamat SK; Thatte UM; Yeolekar ME; Rege NN; Dahanukar SA; Nanivadekar AS J Assoc Physicians India; 1998; Suppl 1():26-9. PubMed ID: 11229106 [TBL] [Abstract][Full Text] [Related]
9. [Effect of erythrocytes on the stability of prostacyclin in healthy subjects and patients with cerebral dyshemias]. Gabrielian ES; Akopov SE; Tunian IuS Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(9):1340-3. PubMed ID: 3535319 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of regulation of tyrosine phosphorylation of NMDA receptor subunit 2B after cerebral ischemia/reperfusion. Pei L; Li Y; Zhang GY; Cui ZC; Zhu ZM Acta Pharmacol Sin; 2000 Aug; 21(8):695-700. PubMed ID: 11501177 [TBL] [Abstract][Full Text] [Related]
11. The mechanism for hypertension following cerebral ischemia. Moore WS; Rosson CT; Thomas AN; Hall AD Surg Forum; 1968; 19():396-8. PubMed ID: 5718680 [No Abstract] [Full Text] [Related]
14. [Function and coagulative activity of blood platelets in patients with attacks of transient cerebral ischemia]. Dmoszyńska-Giannopoulou A Pol Tyg Lek; 1984 Nov; 39(48):1569-71. PubMed ID: 6522313 [No Abstract] [Full Text] [Related]
15. [Efficacy of OSMO-Adalat in patients with arterial hypertension in combination with kinked precerebral arteries]. Khirmanov VN; Tiurina TV; Sorokoumov VA; Zakharova IV Ter Arkh; 2001; 73(9):24-7. PubMed ID: 11642075 [TBL] [Abstract][Full Text] [Related]
18. Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a beta-blocker and a calcium uptake antagonist. Forbes CD; Lowe GD; MacLaren M; Shaw BG; Dickinson JP; Kieffer G Semin Thromb Hemost; 1999; 25 Suppl 2():55-60. PubMed ID: 10440425 [TBL] [Abstract][Full Text] [Related]
19. Changes and mechanisms of protein-tyrosine kinase and protein-tyrosine phosphatase activities after brain ischemia/reperfusion. Pei L; Li Y; Yan JZ; Zhang GY; Cui ZC; Zhu ZM Acta Pharmacol Sin; 2000 Aug; 21(8):715-20. PubMed ID: 11501180 [TBL] [Abstract][Full Text] [Related]
20. Elevated velocity of prostacyclin degradation in blood as a possible risk factor in patients with cerebrovascular disorders. Akopov S; Darbinian V; Grigorian G; Kosyan A; Gabrielian E Eur Neurol; 1993; 33(3):252-5. PubMed ID: 8467849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]